Table 1 Clinicopathological characteristics and PCGEM1 expression of 50 prostate cancer patients
Clinicopathological characteristics | Number | Low PCGEM1 expression (n = 25) | High PCGEM1 expression (n = 25) | P value |
|---|---|---|---|---|
Age | 0.5637 | |||
≥ 60 | 20 | 9 | 11 | |
< 60 | 30 | 16 | 14 | |
Gleason score | 0.0109 | |||
≤ 8 | 25 | 17 | 8 | |
> 8 | 25 | 8 | 17 | |
PSA | 0.6063 | |||
< 10 ng/mL | 16 | 9 | 7 | |
≥ 10 ng/mL | 34 | 16 | 18 | |
TNM stage | 0.0771 | |||
I + II | 32 | 19 | 13 | |
III + IV | 18 | 6 | 12 | |
Distant metastasis | 0.0235 | |||
M0 | 26 | 17 | 9 | |
M1 | 24 | 8 | 16 | |
Extracapsular extension | 0.0366 | |||
Negative | 33 | 20 | 13 | |
Positive | 17 | 5 | 12 |